GSK updates total voting rights and share capital
GSK plc reported its share capital and voting rights as of 30 April 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
6-K
Rhea-AI Filing Summary
GSK plc reported its share capital and voting rights as of 30 April 2026. The company had 4,316,202,660 ordinary shares of 31¼ pence each in issue, including 261,378,286 shares held in treasury. This leaves a total of 4,054,824,374 voting rights for shareholder disclosure calculations.
Key Figures
Issued share capital: 4,316,202,660 shares
Treasury shares: 261,378,286 shares
Total voting rights: 4,054,824,374
+2 more
5 metrics
Issued share capital
4,316,202,660 shares
Ordinary shares of 31¼ pence each as of 30 April 2026
Treasury shares
261,378,286 shares
Ordinary shares held in treasury as of 30 April 2026
Total voting rights
4,054,824,374
Voting rights in GSK plc as of 30 April 2026
Nominal value per share
31¼ pence
Par value of each ordinary share
Reference rule
DTR 5.6.1R
FCA Disclosure Guidance and Transparency Rule governing voting rights notifications
Key Terms
Total Voting Rights, treasury, Disclosure Guidance and Transparency Rule 5.6.1R, Form 20-F, +1 more
5 terms
Total Voting Rights financial
"Therefore, the total number of voting rights in the Company is 4,054,824,374."
The total voting rights number is the count of shares that carry the right to vote at a company’s shareholder meetings, reflecting how much voting power exists in the market. Investors use it to understand control and influence—like knowing how many votes are in play when measuring ownership stakes, calculating a shareholder’s voting percentage, or assessing how easy it would be for a holder to sway decisions.
treasury financial
"of which 261,378,286 Ordinary Shares were held in Treasury."
The treasury is the department or area within a government or organization responsible for managing its money, finances, and financial strategies. It handles tasks like collecting revenue, paying bills, and planning for future financial needs, much like a household manages its budget. For investors, understanding the treasury is important because it influences interest rates, government spending, and overall economic stability.
Disclosure Guidance and Transparency Rule 5.6.1R regulatory
"In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R"
Form 20-F regulatory
"whether the registrant files or will file annual reports under cover of Form 20-F"
Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.
foreign private issuer regulatory
"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What total voting rights did GSK (GSK) report as of 30 April 2026?
GSK reported a total of 4,054,824,374 voting rights as of 30 April 2026. Shareholders can use this figure as the denominator when calculating whether they must notify holdings under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.
Why did GSK (GSK) publish total voting rights information?
GSK published total voting rights information to comply with FCA Disclosure Guidance and Transparency Rule 5.6.1R. The disclosed voting rights figure helps shareholders determine when they must notify the company and regulators about their interests or changes in their shareholdings.
Which SEC annual report form does GSK (GSK) use as a foreign issuer?
GSK files its annual reports under Form 20-F as a foreign private issuer. Form 20-F is the standard SEC reporting format for non-U.S. companies whose securities trade in the United States, aligning with U.S. disclosure and accounting requirements.
How can investors contact GSK (GSK) about disclosure notifications?
Investors can send disclosure notifications to GSK via company.secretary@gsk.com. This email contact is provided for shareholders calculating positions against the published voting rights figure and needing to report interests under UK Financial Conduct Authority transparency rules.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates